Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05581368Recruiting

Studying the Effects of Cannabis on Vasculature

Role: collaborator

NCT06634108Phase 1Recruiting

Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy

Role: collaborator

NCT06541509Phase 1Recruiting

Mechanisms of Semaglutide Therapy in Heart Failure Patients

Role: collaborator

NCT06501768Phase 1Recruiting

Cardiovascular Genistein Therapy for Heart Failure Inflammation

Role: collaborator

All 4 trials loaded